BasicsProtocolGuide

Reconstitution: The Step Most Peptide Protocols Get Wrong

Matt Roberts·22 June 2026·6 min read
Research purposes only. The compounds discussed in this article are research chemicals, not licensed medicines. Nothing on this site constitutes medical advice, diagnosis, or a recommendation to use any substance. Always consult a qualified healthcare professional before making any changes to your health regimen.

There's a particular frustration that shows up repeatedly in peptide forums. Someone runs a carefully researched protocol for eight weeks, logs everything diligently, and at the end of it concludes the compound doesn't work for them — when the more likely explanation is that what they injected bore little resemblance to what they thought they were taking. Not because the product was low quality. Because the reconstitution was wrong.

Dosing gets obsessed over. Compound selection gets obsessed over. The mixing step gets treated as an afterthought. That's the wrong order of priorities.

Why Peptides Come as Powder

Lyophilisation — freeze-drying — is how manufacturers solve the stability problem. In solution, peptides are vulnerable. Temperature changes, light exposure, bacterial contamination, and simple molecular degradation all degrade active compound over time. In powdered form, with the moisture removed and the vial sealed under inert gas, most peptides are stable for years at room temperature. The same peptide in solution has a shelf life measured in weeks.

This means the powder in the vial you receive is at its most stable. Everything you do from the moment you add water introduces instability — which is why how you reconstitute matters, how you store the result matters, and how quickly you use it matters.

The Right Diluent

Bacteriostatic water is the correct choice for almost all research peptides. It's sterile water with 0.9% benzyl alcohol added — the benzyl alcohol acts as a preservative, inhibiting bacterial growth in the vial after you've punctured the stopper. This is what gives reconstituted peptides a practical shelf life of two to four weeks in the refrigerator rather than a few days.

Plain sterile water will technically reconstitute a peptide, but without the preservative, the reconstituted solution is vulnerable to contamination from the moment you open it. A single vial of peptide used across multiple injections over several weeks is exactly the kind of situation bacteriostatic water is designed for.

Normal saline is sometimes suggested as an alternative and is fine for single-use reconstitution, but for ongoing multi-injection vials, bacteriostatic water is what you want. Some people use acetic acid water for specific peptides — most commonly for growth hormone — but for the peptides most people are using, bacteriostatic water is the standard.

How You Add the Water Matters

This sounds like unnecessary pedantry until you understand the mechanism. Injecting water forcefully directly onto a peptide powder can break peptide bonds through mechanical shear. Peptides are not robust molecules — they're chains of amino acids linked by bonds that can be disrupted by more than just heat and light.

The correct method is to inject the bacteriostatic water slowly down the side of the vial, letting it run down to meet the powder rather than blasting it. The powder will dissolve on its own. If it doesn't dissolve immediately, gently roll the vial between your palms. Vortexing or shaking introduces the same mechanical forces you're trying to avoid. Patience here is not a nicety — it's part of the protocol.

Let the vial come to room temperature before adding water if it's been refrigerated. Cold water added to cold powder dissolves less readily and increases the temptation to agitate.

Getting the Concentration Right

This is where the real dosing errors happen, and they're often not caught because the person never double-checks their arithmetic.

The concentration you create when you reconstitute determines every single dose you draw from that vial. If you're working with a 5mg vial and you add 2ml of bacteriostatic water, you have a solution at 2.5mg/ml, or 2500mcg/ml. A target dose of 250mcg means you need to draw 0.1ml — which on a standard U100 insulin syringe is 10 units. If you add 1ml instead, your concentration doubles. That same 10 units now delivers 500mcg. Two to one error. Not from buying a bad product. From a different volume of water.

The arithmetic is not complicated, but it needs to be done correctly and written down, not kept in your head. The relationship between vial peptide content, water volume, target dose, and injection volume is fixed — change any one of those variables and every subsequent dose changes with it.

Peptidy's reconstitution calculator handles this directly. Enter the vial size and the volume of water you've added, set your target dose, and it gives you the exact injection volume in both millilitres and insulin syringe units. That output becomes your protocol reference for that vial — the number you work from every time you draw a dose.

Storage After Reconstitution

Reconstituted peptides go in the refrigerator. Not the freezer — freeze-thaw cycles degrade peptides faster than stable refrigeration, despite the intuition that colder is better. The goal is 2–8°C and stable. Most domestic fridges are fine for this.

Light is also a factor for some peptides, particularly those containing aromatic amino acids that are photosensitive. The simplest approach is to keep reconstituted vials in the box they came in, or wrapped in foil, rather than in the door of the fridge where they're exposed every time you open it. Some suppliers ship in amber vials for exactly this reason.

The two-to-four week stability window assumes reasonable storage conditions. Leaving a reconstituted vial at room temperature for extended periods, or going in and out of temperature ranges, shortens that window considerably. If a reconstituted peptide starts to look cloudy or develops particles, discard it.

The Cascade Effect of Getting This Wrong

What makes reconstitution errors pernicious is that they corrupt every conclusion you draw from a protocol. An under-dosed protocol that doesn't produce results doesn't tell you the peptide doesn't work — it tells you the dose you thought you were taking isn't the dose you were taking. An over-concentrated vial where you inject two to three times the intended dose explains a lot of the unexpected side effect reports that get attributed to the compound itself.

Tracking injections properly compounds this. If you know you added 2ml of bacteriostatic water to a 5mg vial and you've logged every injection, Peptidy can show you how much of the vial you've used and how much should remain. That's a sanity check that catches concentration errors — if you've logged 30 doses of 250mcg from a 5mg vial, something doesn't add up. Catching that early is better than running a defective protocol for another month.

Why This Matters More Than Compound Selection

The peptide market has become reasonably good at producing quality product. Third-party tested suppliers with verifiable certificates of analysis are not hard to find. The failure point, more often than people want to admit, is what happens between opening the package and completing the injection.

A protocol built on correct reconstitution, accurate dosing, consistent logging, and proper storage gives you something you can actually evaluate. You can assess whether the compound is working, adjust the dose with confidence, and draw conclusions that mean something. A protocol where any of those steps is guessed at gives you noise — and the conclusions drawn from noise tend to be wrong.

The preparation is not glamorous. It's not the part people discuss when they're comparing notes on compounds. But it's the part that determines whether everything else is actually worth doing.